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Distinct Structure and Signaling Potential
of the TCR Complex
of the mature TCR. Signals transduced by the TCR
are thought to regulate the commitment of immature DN
cells to the  T cell lineage (Kang et al., 1998b) and are
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Bethesda, Maryland 20892 Because the pre-, -, and TCRs can transduce
signals that regulate lineage commitment and thymo-
cyte maturation, understanding how their structures and
Summary signaling properties differ is of particular interest. The
pre- and TCRs are composed of a clonotypic hetero-
 and  T cells are distinguished by the clonotypic dimer (TCR-  pT or TCR-  TCR-, respectively)
subunits contained within their TCRs. Although the and a signal transducing complex consisting of two CD3
TCR has been well characterized, much less is subunit dimers, CD3 and CD3, and a TCR- chain
known about the TCR. Here, we report that, unlike homodimer (Samelson et al., 1985; Berger et al., 1997).
TCRs, most TCRs expressed on ex vivo  T cells The structure of the TCR has been reported to resem-
lack CD3. Despite this structural difference, signal ble that of the TCR (Krangel et al., 1987; Cron et al.,
transduction by the TCR is superior to that of the 1988; Van Neerven et al., 1990), except that the TCR
TCR, as measured by its ability to induce calcium can include the FcRI  (FcR) chain (Qian et al., 1993;
mobilization, ERK activation, and cellular proliferation. Park et al., 1995), a TCR- family member that also func-
Additionally, the TCR complexes expressed on primary tions as a subunit of the FcRI, FcRI, and FcRIII recep-
 T cells contain only  homodimers; however, fol- tors (reviewed by Nadler et al., 2000; Ravetch and Bol-
lowing activation and expansion, FcR1  is expressed land, 2001). FcR can form homodimers or heterodimers
and is included in the TCR complex. These results with TCR- (Orloff et al., 1990). Therefore, three unique
reveal fundamental differences in the primary struc- TCR complexes can theoretically be expressed on the
ture and signaling potential of the - and TCR surface of  T cells, those containing , , or 
complexes.
dimers.
The generation of mice with targeted mutations of
Introduction
genes encoding the invariant TCR chains has revealed
differences in the subunit requirements for  and  TIn all jawed vertebrates, there are two T cell lineages,
cell development. Null mutation of any one of the invari-defined by the expression of either the clonotypic T cell
ant subunits of the TCR (CD3, CD3, CD3, or TCR-)receptor (TCR), -, or - heterodimer in their antigen
has profound effects on  T cell development, resultingreceptor complexes.  and  T cells originate in the
in the marked reduction or absence of mature TCRthymus from a common precursor but diverge into sepa-
cells (Love et al., 1993; Liu et al., 1993; Malissen et al.,rate lineages early in ontogeny (Petrie et al., 1992). 
1993, 1995; Dave et al., 1997; DeJarnette et al., 1998;T cell development begins at the immature CD4 CD8
Haks et al., 1998). Although deletion of CD3, CD3, or(DN) stage following the successful rearrangement of
TCR- also blocks  T cell development (Love et al.,the TCR- locus. The TCR- chain associates with the
1993; Liu et al., 1993; Malissen et al., 1993, 1995; DeJar-invariant pre-T (pT) chain and the invariant signal-
nette et al., 1998; Haks et al., 1998), loss of CD3 hastransducing CD3 and TCR- subunits to form the pre-
no effect on the generation of matureTCR cells (DaveTCR (Groettrup et al., 1993; Berger et al., 1997). Signals
et al., 1997). In addition, loss of FcR does not appeartransduced by the pre-TCR induce cell proliferation, ini-
to inhibit  T cell development (Heiken et al., 1996;tiation of rearrangements at the TCR- locus, and transi-
Shores et al., 1998), despite the fact that FcR is re-tion to the CD4 CD8 (DP) stage (von Boehmer and
ported to be a component of the TCR.Fehling, 1997). Synthesis of the TCR- chain in DP thy-
To determine why the reported structure of the TCRmocytes results in expression of the mature TCR.
did not correlate with the subunit requirements for  TTCR DP thymocytes then undergo positive and neg-
cell development, we examined the subunit compositionative selection, ultimately emerging as functionally ma-
of the TCR expressed on ex vivo  T cells from TCRture CD4 or CD8 T cells (reviewed by Jameson et al.,
transgenic (Tg) (Sim et al., 1995) and non-TCR Tg1995; Sebzda et al., 1999).  T cell development also
mice. Here, we report that most TCRs on primary begins at the immature DN stage; however,  T lineage
T cells lack not only FcR but also CD3. Despite thecells do not proceed through developmental stages de-
fined by the expression of a pre-TCR or CD4/CD8 core- absence of CD3, signal transduction by the TCR is
ceptors (Pardoll et al., 1988; Kang et al., 1998a). Instead, superior to that of the TCR, as measured by its ability
in-frame rearrangements of both the TCR- and TCR- to induce calcium mobilization, MAPKinase activation,
genes in DN thymocytes result in the surface expression and cellular proliferation. Together, these observations
call for a revision in our perception of the structure and
signaling potential of the TCR complex.1Correspondence: pel@helix.nih.gov
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Figure 1.  T Cell Development in TCR Tg Mice Lacking Either the TCR- Chain or the FcR Chain
Thymocytes and lymph node cells were harvested and enumerated, and the resulting numbers are shown for each genotype. Percentages
of CD4 CD8 (DN) and CD4 CD8 (DP) thymocyte subsets and lymph node DN, CD4, and CD8 subsets are shown in the appropriate
quadrants of the CD4 versus CD8 staining profiles. TCR expression on gated DN subsets is shown in the adjacent histograms, and the
percentage of TCR cells among DN cells is provided. Results are representative of four experiments.
Results DN thymocytes and lymph node cells (Figure 1), confirm-
ing the previous finding that TCR- is required for assem-
bly and surface expression of the TCR complex (LoveLoss of TCR- but Not FcR Blocks Development
of Peripheral Lymphoid  T Cells et al., 1993; Khattri et al., 1996; Shores et al., 1998). In
contrast, no significant difference was detected in thePrevious studies have shown that loss of FcR does not
affect the generation of normal numbers of  T cells in percentage and number of DN TCR cells in the thy-
mus and lymph nodes of FcR/ TCR Tg and FcR/both secondary lymphoid organs and epithelial organs
(Heiken et al., 1996; Shores et al., 1998). This finding is TCR Tg mice (Figure 1). These results agree with our
previous findings (Shores et al., 1998) and those ofinconsistent with the fact that FcR has been reported
to be a component of the TCR complex (Qian et al., Heiken et al. (1996), indicating that T cell development
is not impaired in the absence of the FcR chain.1993; Park et al., 1995). Because  T cells are normally
present in such low numbers in the thymus and second- We previously reported that a human FcR transgene
can partially reconstitute  T cell development in TCR-ary lymphoid organs, it may be difficult to detect effects
on their development caused by the loss of FcR. To / mice (Shores et al., 1997). To determine if FcR can
support  T cell development in the absence of TCR-overcome this problem, we mated TCR-/ and FcR
/ mice to mice that express the V6-J1-C1 and V1- , we mated the human FcR transgene onto the TCR
Tg/TCR-/ background. While constitutive overex-D1-J2-C TCR transgenes (hereafter referred to as
TCR Tg; Sim et al., 1995), which contain large numbers pression of the human FcR chain was able to support
assembly and surface expression of the TCR on thy-of CD4 CD8 (DN) cells in the thymus and periphery
that express the TCR (Figure 1). When the TCR mocytes, it was not able to support maturation of most
 T cells, as demonstrated by the marked decrease intransgene was mated onto the TCR-/ background,
TCR surface expression was nearly undetectable on the percentage and number of DN TCR cells in the
TCR Structure and Signaling Potential
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Figure 2A, only TCR- was detected in TCR complexes
from ex vivo lymph node  T cells obtained from both
TCR Tg and TCR-/ mice. FcR was not detected
in the anti-TCR immunoprecipitates (Figure 2A), even
after long exposure times (data not shown). These re-
sults agree with those of Guy-Grand et al. (1994) who
detected TCR- but not FcR  transcripts in lymph node
 T cells. Based on these findings, we conclude that
FcR is not a component of the TCR on ex vivo periph-
eral  T cells.
Our results appear to conflict with those of Qian et
al. (1993), who reported that FcR is a major subunit of
the TCR complex. However, a difference between our
own and the previous study is that we analyzed unstimu-
lated ex vivo  T cells, while Qian et al. (1993) analyzed
 T cells that had first been stimulated and expanded
in vitro in the presence of exogenous IL-2. To determine
whether this difference could explain the conflicting re-
sults, we cultured T cells fromTCR Tg mice in condi-
tions similar to those reported by Qian et al. (1993) and
then used biochemical analyses to identify the subunits
of the TCR complex. Interestingly, FcR chain was
detected as a component of the TCRs expressed on
in vitro stimulated  T cells, but again was not present
in TCRs expressed on primary  T cells (Figure 2B).
Two-dimensional SDS-PAGE of surface biotinylated
complexes revealed that the TCRs expressed on the
surface of stimulated  T cells contained FcR/TCR-
heterodimers and FcR homodimers in addition to 
Figure 2. Inclusion of the FcRChain in the TCR Complex Follow-
homodimers (Figure 2C). Together, these data suggesting Activation
that TCR stimulation and expansion in the presence of(A) Ex vivo lymph node cells were lysed and incubated with anti-
IL-2 induces the incorporation of FcR into the TCRTCR- mAb H57-597 (for B6 and FcR Tg mice) or anti-TCR mAb
complex.UC7-13D5 (for TCR Tg and TCR-/). Proteins were resolved by
reducing SDS-PAGE, transferred to PVDF membranes, and immu-
noblotted with anti-TCR- or anti-FcR serum. Most TCRs Expressed on Ex Vivo Peripheral
(B and C)  T cells from TCR Tg mice were activated by anti-
Lymphoid  T Cells Lack CD3TCR mAb (GL4) and expanded in vitro in the presence of IL-2 for
The subunit composition of the TCR on ex vivo  T cells6 days.
was examined further by analyzing surface-biotinylated(B) Lysates from unactivated (ex vivo) or activated (stim.)  T cells
were immunoprecipitated with anti-TCR (UC7-13D5), resolved by TCR complexes. Ex vivo  T cells were purified from
SDS-PAGE, transferred to PVDF membranes, and immunoblotted TCR Tg and TCR-/ mice. For comparison, lymph
for FcR chain. node  T cells were purified from B6 mice and exam-
(C) Unactivated and activated  T cells were surface biotinylated,
ined in parallel. Significantly, these experiments re-lysed, and incubated with anti-TCR (UC7-13D5). Immunoprecipi-
vealed that the subunit composition of the CD3 complextated proteins were resolved by 2D nonreducing/reducing SDS-PAGE
expressed on the surface of  T cells differed from thatand transferred to PVDF membranes. Biotinylated TCR subunits
were detected with horseradish peroxidase- conjugated avidin-bio- expressed on  T cells, in that most TCRs lacked
tin complexes. The positions of , , and  dimers are shown. CD3 (Figure 3A). The same subunit composition was
observed when TCR complexes from TCR-/ mice
were analyzed (Figure 3A), demonstrating that the ab-
lymph nodes (Figure 1). The inability of the human FcR sence of CD3was not specific to the transgenic TCR
chain to support  T cell development was also ob- complex. Analysis of surface TCR complexes ex-
served in non-TCR Tg/huFcR Tg/TCR-/ mice, as pressed on thymocytes from TCR Tg and TCR-/
evidenced by a 3-fold decrease in the number of DN mice yielded similar results (data not shown).
TCR cells in both the thymus and lymph nodes (data To visualize better the CD3 subunits, we analyzed
not shown). Together, these results demonstrate that surface-biotinylated TCR complexes by 2-D SDS
TCR-but not FcR is required for T cell development. PAGE. Again, CD3was nearly undetectable, regardless
of whether anti-TCR or anti-TCR- mAb was used to
immunoprecipitate the TCR complex (Figure 3B). TheInclusion of FcR into the TCR Complex
Following Activation same result was obtained when TCR complexes were
immunoprecipitated with the anti-CD3 mAb, 145-2C11The results from our in vivo studies suggested that the
TCR complexes on primary  T cells may contain only (Figure 3B). Since mAb 145-2C11 binds to CD3 chains
paired with either CD3 or CD3 chains, this result dem- homodimers. To confirm this, we determined whether
FcR could be detected within immunoprecipitated onstrates that the absence of CD3 from TCR com-
plexes cannot be attributed to the loss of CD3 dimersTCR complexes by Western blotting. As shown in
Immunity
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Figure 3. Subunit Composition of TCR Com-
plexes on Ex Vivo  and  T Cells
(A) Purified lymph node  T cells from B6
mice or  T cells from TCR Tg or TCR-
/ mice were surface biotinylated, lysed in
Brij 97 buffer, and incubated with anti-TCR-
(mAb H146). Immunoprecipitated proteins
were resolved by reducing SDS-PAGE and
transferred to PVDF membranes. Biotinylated
TCR subunits were visualized with ABC-HRP.
The positions of the TCR, CD3, and  subunits
are marked.
(B) Lymph node  and  T cells were puri-
fied from B6 and TCR Tg mice, respec-
tively, and their surface proteins were labeled
with biotin. - and TCR complexes were
immunoprecipitated from cell lysates using
anti-TCR mAbs (H57-597 and UC7-13D5, re-
spectively), anti-TCR- mAb (H146), or anti-
CD3 mAb (145-2C11). Immunoprecipitated
proteins were resolved by nonreducing/
reducing 2D SDS-PAGE and transferred to
PVDF membranes. ABC-HRP and chemilumi-
nescence were used to visualize surface bio-
tinylated proteins. The positions of the CD3
subunits are marked. The boxed region
shows the TCR- homodimer at a longer ex-
posure time.
(C) Human peripheral blood lymphocytes
were surface labeled with biotin. - and
TCR complexes were immunoprecipitated
from cell lysates using anti-TCR mAbs
BMA031 and 5A6.E9, respectively. Immuno-
precipitated proteins were resolved by nonre-
ducing/reducing 2D SDS-PAGE and trans-
ferred to PVDF membranes. ABC-HRP and
chemiluminescence were used to visualize
surface biotinylated proteins. The positions
of the CD3 subunits are marked. The boxed
region shows the TCR- homodimer at a
longer exposure time.
during immunoprecipitation due to weak association cells. Northern blot analysis demonstrated that purified
 and  T cells contain similar amounts of CD3 tran-with the TCR. These findings strongly suggested that
the CD3 chain is not a structural component of most scripts (Figure 4A). However, the amount of total cellular
CD3 protein was much lower in  T cells than in TCR complexes on ex vivo TCR thymocytes and
lymph node cells. T cells (Figure 4B). As most of the CD3 protein is associ-
ated with surface TCR complexes in  T cells, theWe next examined the subunit composition of the
TCR complex on primary human peripheral blood  T relative paucity of total cellular CD3 protein in  T
cells is consistent with our observation that CD3 is notcells to determine whether the absence of CD3 from the
TCR has been conserved in mammals. The molecular expressed on the cell surface.
To investigate the intracellular fate of CD3 in  Tmasses of the human CD3 subunits are different than
those of the murine CD3 subunits, as a consequence cells, we designed an experiment to compare, between
 and  T cells, the relative amounts of unpaired CD3of differential glycosylation (reviewed by Klausner et al.,
1990). As shown in Figure 3C, little or no CD3 was chains and of CD3 dimers that are unassembled or
contained within partially assembled TCR complexes.detected in surface TCRs expressed by human  T
cells. The absence of CD3 from most human TCR  and  T cells were lysed and fully assembled; TCR
complexes were precleared with two rounds of anti-complexes was also confirmed by immunoblotting (data
not shown). These results, together with those from the TCR- immunoprecipitation. Consistent with our previ-
ous findings, fully assembled TCR complexes con-analysis of the murine TCR, reveal a fundamental dif-
ference in the primary structure of - and TCR com- tained extremely low amounts of CD3 compared to
TCR complexes (Figure 4C). Lysates precleared ofplexes.
fully assembled TCR complexes were then incubated
with anti-CD3 mAb to recover unassembled CD3 di-Synthesis of CD3 in  T Cells
To determine why CD3 was not a subunit of most sur- mers and partially assembled TCR complexes, followed
by anti-CD3 to recover unpaired CD3 chains. Asface TCR complexes, we next examined the expres-
sion level of CD3 mRNA and protein in ex vivo  T shown in Figure 4C, the amount of unpaired CD3 chain
TCR Structure and Signaling Potential
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Figure 4. Expression of CD3 mRNA and
Protein in  T Cells
(A) Detection of CD3, -, -, and TCR- tran-
scripts in purified populations of lymph node
 or  T cells by Northern blot. Total RNA
from the mouse fibroblast cell line, L929, was
used as a negative control. Blots were also
probed with labeled ef-1 cDNA to assess
loading.
(B) Total cellular CD3 and CD3 protein lev-
els in purified  or  T cells. Total cell ex-
tracts were analyzed by Western blot with
polyclonal antisera against CD3 or CD3.
(C) Relative amounts of unpaired CD3 and
CD3 dimers in  and  T cells. Cell lysates
were subjected to sequential immunoprecipi-
tation with anti-TCR (mAb H146) (2 rounds)
followed by anti-CD3 (mAb 145-2C11) fol-
lowed by polyclonal anti-CD3. Immunopre-
cipitated proteins were resolved by SDS-
PAGE, transferred to PVDF membranes, and
blotted with anti-CD3 (or anti-TCR to as-
sess the efficiency of immunoprecipitation).
was similar in  and  T cells. In contrast,  T cells mobilize Ca2, and to activate the ERK/MAPKinase path-
way (Delgado et al., 2000; Werlen et al., 2000). To com-contained lower amounts of CD3 dimers. Therefore,
these results suggest that synthesis of CD3 is equiva- pare directly the signaling response of - and TCRs,
ex vivo  and  T cells were purified and activatedlent in  and  T cells (as assessed by the level of
CD3monomers), but that either CD3dimer formation/ by TCR crosslinking with the same stimulating antibody,
mAb 145-2C11(anti-CD3). As shown in Figure 6A, bothstability is impaired in  T cells or CD3 dimers are
excluded during TCR assembly. phosphorylated forms of TCR-, p21 and p23, were de-
tected in anti-CD3 immunoprecipitates of  and  TTo discern between these possibilities, we next ana-
lyzed the subunit composition of - and TCRs ex- cell lysates following stimulation by TCR crosslinking.
Interestingly, p21, which is detected in nonstimulatedpressed on the same cell. Saito et al. (1988) generated
a T cell hybridoma (DN1-.-1.3) that expresses both as well as activated  T cells, was far less abundant
in nonstimulated  T cells. Nevertheless, the amount- and TCRs by transfecting the TCR- and - genes
from the 2B4  T cell hybridoma into the  T cell of p23, which represents the fully phosphorylated form
of TCR-, was similar in  and  T cells activated byhybridoma DN7.1 (Korman et al., 1988). Both receptor
complexes are expressed on the cell surface (Figure TCR crosslinking (Figure 6A). In addition, engagement
of the TCR and TCR led to the generation of similar5A). The TCR on the dual receptor-bearing hybridoma
contained CD3 (Figure 5B), demonstrating that CD3 amounts of phospho-LAT (Figure 6B).
TCR thymocytes from mice lacking CD3 display andimers form properly in this cell line. However, as ob-
served in ex vivo  T cells, the TCR did not contain impaired Ca2 response following CD3 crosslinking (Del-
gado et al., 2000). Therefore, we investigated whether exCD3 (Figure 5B). Moreover, the absence of CD3 di-
mers within surface TCRs is not due to limiting vivo peripheral  T cells can mobilize Ca2 following
CD3 crosslinking. The levels of CD3 expression for theamounts of CD3 dimers in these cells, as non-TCR-
associated CD3 dimers were detected following pre- four T cell populations analyzed (Figure 6C), presented
as mean fluorescence intensity units, were: 94 for CD8clearing with antibodies against the - and TCRs
(Figure 5C). Taken together, these results suggest that  T cells, 115 for DN  T cells (pT/), 183 for CD4
 T cells, and 246 for DN  T cells (TCR Tg). How-CD3 dimers fail to associate with the chains of the
TCR- heterodimer and, therefore, are not transported ever, there was no apparent correlation between CD3
surface levels and Ca2 response, since CD8 and CD4to the surface.
 T cells mobilized calcium with similar kinetics and
amplitude (Figure 6D). Significantly, both  T cell popu-Signaling Potential of the TCR Complex
The absence of CD3 could affect both the strength and lations mobilized calcium with faster kinetics and
greater amplitude than either  T cell population, espe-quality of the signals transduced by the TCR on ex vivo
peripheral  T cells. Indeed, others have shown that cially when lower concentrations of anti-CD3 were used
for stimulation (Figure 6D).engagement of TCR complexes lacking CD3 fails to
induce phosphorylation of TCR- and LAT, to efficiently Using different in vivo systems, Delgado et al. (2000)
Immunity
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Figure 5. Subunit Composition of - and TCR Complexes Expressed on a Dual Receptor-Bearing T Cell Hybridoma
(A) Histograms showing the staining pattern of anti-CD3 (145-2C11), anti-TCR (H57-597), and anti-TCR (GL3) mAbs on DN1-.-1.3 cells.
(B) DN1-.-1.3 cell lysates were incubated with either anti-TCR (mAb H57-597) or anti-TCR (mAb UC7-13D5) and immunoprecipitates
were resolved by SDS-PAGE, transferred to PVDF membranes, and blotted with antibodies against the CD3 and CD3 chains.
(C) DN1-.-1.3 cell lysates were subjected to sequential immunoprecipitation with anti-TCR (mAb H57-597), then anti-TCR (mAb UC7-
13D5), and then polyclonal anti-CD3. Immunoprecipitated proteins were resolved by SDS-PAGE, transferred to PVDF membranes, and blotted
with anti-CD3.
and Werlen et al. (2000) reported that the CD3 subunit proliferation is markedly enhanced by CD28 costimula-
tion. However, CD28 costimulation did not enhanceplays a critical role in thymocyte-positive selection by
coupling the TCR to the ERK signaling pathway. To TCR-induced proliferation. In fact, the proliferative re-
sponse of  T cells induced by CD3 crosslinking alonedetermine whether absence of CD3 similarly compro-
mises TCR signaling responses, we tested whether was equivalent to that of  T cells induced by anti-
CD3 and anti-CD28 (Figure 7C). Notably, no significantthe ERK pathway could be activated by TCR engage-
ment of  T cells from TCR Tg mice. As shown in difference in the percentages of dividing cells was ob-
served between the two T cell populations followingFigure 7A, the kinetics of ERK activation were similar in
 and  T cells. In addition, the magnitude of ERK stimulation with PMA and ionomycin, indicating that 
T cells are not inherently more responsive to activatingphosphorylation was found to be consistently greater
in  T cells than in  T cells at each time point (Figure signals than  T cells (Figure 7C). These results demon-
strate the TCR can transduce efficient proliferative7A and data not shown). TCR crosslinking was also
capable of activating JNK and p38 (Figure 7A and data signals in the absence of CD28 costimulation.
not shown). Lastly, we observed that ERK could also
be activated in polyclonal populations of  T cells from Discussion
TCR-/ mice by TCR crosslinking (Figure 7B).
In comparison to the TCR, relatively few studies have
focused on the TCR. Consequently, our perceptionTCR Engagement Induces a Strong Proliferative
Response in the Absence of Costimulation of the TCR has been largely based upon extrapolation
from experiments conducted on  T cells. To remedyOur biochemical analysis of TCR signaling potential
suggested that the TCR may transduce signals better this, we performed a detailed analysis of the structure
and signaling potential of the TCR on ex vivo  Tthan the TCR. To determine whether this increased
signaling proficiency affected the kinetics of T cell acti- cells from TCR Tg, pT/, and TCR-/ mice. These
experiments yielded several significant findings. First,vation, we compared the proliferative capacity of 
and  T cells following CD3 crosslinking. Lymph node they demonstrated that while TCR- is a subunit of
TCR complexes on primary  T cells, FcR is not. and  T cells were purified from B6 and TCR Tg
mice, respectively, labeled with CFSE, and stimulated Second, these experiments revealed a more striking dif-
ference in the subunit composition of the TCR and thefor 48 hr with varying concentrations of immobilized
anti-CD3 (mAb 145-2C11). At every concentration of TCR, in that CD3 chain is absent from most TCRs
expressed on primary  T cells from both mice andanti-CD3 examined, the proliferative response of  T
cells was found to be greater than that of  T cells humans. Third, whereas stimulation of TCRs that lack
CD3 fails to activate the ERK pathway (Delgado et al.,(Figure 7C and data not shown). One possible explana-
tion for the difference in the kinetics of T cell activation 2000; Werlen et al., 2000), stimulation of the TCR leads
to the activation of ERK as well as other important ef-between  and  T cells may be that  T cells are
more dependent on CD28 costimulation than  T cells. fector molecules in the TCR signaling pathway. Fourth,
comparison of the signaling potential of the TCR andTo address this, we stimulated purified  and  T cells
in the presence or absence of anti-CD28 and measured TCR indicated that the TCR transduces signals bet-
ter than the intact TCR. Collectively, these observa-their proliferative responses. As shown previously
(Gross et al., 1992) and in Figure 7C, TCR-induced tions reveal a fundamental difference in the primary
TCR Structure and Signaling Potential
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Figure 6. Comparison of Signaling Events in  and  T Cells Following TCR Stimulation
Lymph node  and  T cells were purified from B6 and TCR Tg mice, respectively, and stimulated by crosslinking with biotinylated anti-
CD3 mAb (145-2C11) plus streptavidin for the indicated times in minutes.
(A) Tyrosine phosphorylation of TCR- was detected by Western blot analysis of anti-CD3 immunoprecipitates with mAb, 4G10. The positions
of the p21 and p23 forms of TCR- are shown. Blots were subsequently stripped and probed with anti-TCR- (bottom).
(B) Tyrosine phosphorylation of LAT was detected by Western blot analysis of anti-LAT immunoprecipitates with mAb, 4G10. Total LAT levels
in cell lysates were detected by immunoblotting with anti-LAT serum (bottom).
(C) Lymph node cells from B6, pT /, and TCR Tg mice were stained with antibodies against the CD4, CD8, and CD3 surface antigens.
The histogram shows the levels of CD3 expression on gated CD4 and CD8  T cells from B6 mice and gated DN cells from pT / and
TCR Tg mice.
(D) Lymph node cells from B6, pT /, and TCR Tg mice were loaded with the Ca2 dye indo-1 and then stained with antibodies against
surface antigens (CD4 and CD8 for  T cells and CD4, CD8, TCR, and B220 for  T cells). The cells were stimulated by the addition of
1.0 or 5.0 	g of biotinylated anti-CD3 (145-2C11) at 30 s (first arrow) and 20 	g/ml of streptavidin (crosslinking agent) at 60 s (second arrow).
y axis represents the amplitude of the Ca2 response measured as the ratio of fluorescence between bound and unbound indo-1 (FL4/FL5),
and the x axis represents the amount of time in minutes for which Ca2 mobilization was measured. Results are presented as the Ca2
response for each gated population, with  T cells defined as CD4 CD8 B220TCR.
structure and signaling potential of the - and TCR thymocytes express FcR and incorporate this subunit
into their TCRs. This connection between activation andcomplexes.
The current results demonstrate that the subunit com- induced expression of FcR in TCRs may explain why
peripheral  T cells as well as TCR and TCRposition of the TCR complex can vary depending on
the activation state of the  T cell. Naive or ex vivo iIEL and NK T cells, which have been shown to contain
FcR as a component of their TCRs (Koyasu, 1994; Parkprimary  T cells do not express FcR and their TCRs
associate exclusively with  homodimers. However, fol- et al., 1995), develop in normal numbers in FcR/ mice
(Shores et al., 1998). The introduction of FcR into thelowing activation and expansion in vitro, FcRwas found
to be a subunit of the TCR. Despite the inclusion of TCR complex may influence signaling through the
TCR, since FcR contains only one immunoreceptorFcR, the majority of TCR complexes still contained
 homodimers after in vitro activation. As our culture tyrosine-based activation motif (ITAM), whereas TCR-
contains three ITAMs. Indeed, the TCR signaling re-period lasted only 6 days, it is conceivable that longer
periods of stimulation and expansion and/or different sponse is attenuated when TCR- homodimers are re-
placed by FcR homodimers (Ohno et al., 1993; Liu etstimulation conditions may increase the number of com-
plexes containing  and  dimers. Indeed, TCR al., 1997; Shores et al., 1997). Future studies should
reveal whether the change in TCR structure observedintestinal intraepithelial lymphocytes (iIEL), which are
constantly exposed to antigen, express only  and  following activation and expansion impacts TCR sig-
naling and  T cell function.dimers (Park et al., 1995). Activation-induced expression
of FcR has been previously reported in  T cells. Guy- Our finding that most TCRs expressed on primary 
T cells do not contain CD3 contrasts with those ofGrand et al. (1994) and Heiken et al. (1996) demonstrated
that cellular activation induces FcR gene transcription previous studies in which all of the CD3 subunits includ-
ing CD3 were detected as components of the TCRin  T cells. Furthermore, Koyasu (1994) has shown
that, when cultured in medium containing IL-2, TCR (Krangel et al., 1987; Cron et al., 1988; Van Neerven et
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Figure 7. Comparison of MAPKinase Activation and Proliferation in  and  T Cells Following TCR Stimulation
(A) Lymph node  and  T cells were purified from B6 and TCR Tg mice, respectively, and stimulated by crosslinking with biotinylated
anti-CD3 mAb (145-2C11) plus streptavidin for the indicated times in minutes. Western blot analyses were used to detect phosphorylation of
ERK1/2 and JNK with antibodies specific for p-ERK1/2 and p-JNK, respectively. Total ERK1/2 and JNK levels in cell lysates were determined
by stripping and reblotting with antibodies that detect all forms of ERK1/2 and JNK.
(B) Purified  and  T cells from B6 and TCR-/ mice, respectively, were stimulated by CD3 crosslinking for the indicated times in minutes.
Western blot analysis was used to detect phosphorylation of ERK1/2. Total ERK1/2 levels in cell lysates were determined by immunoblotting
with antibodies that detect all forms of ERK1/2.
(C) Purified ex vivo  and  T cells were CFSE labeled and stimulated on 12-well plates with immobilized anti-CD3 (145-2C11, 10 	g), anti-
CD28 (37.51, 10 	g), anti-CD3 and anti-CD28 (10 	g each) or with PMA and ionomycin. After 48 hr, proliferation was assessed by flow
cytometric analysis on live cells, as determined by forward and side scatter. The percentage of cells within each CFSE peak is given.
al., 1990). A major difference between our own and the this idea. First,  T cell development is blocked in the
absence of CD3 (Haks et al., 1998), but not in the ab-previous studies is that we analyzed unstimulated ex
vivo  T cells, while other investigators analyzed acti- sence of CD3 (Dave et al., 1997). Second, when portions
of the C regions of TCR- and TCR-, which includevated  T cell clones and  T cell hybridomas (Krangel
et al., 1987; Cron et al., 1988; Van Neerven et al., 1990). the transmembrane domains, were substituted for the
corresponding regions of TCR- and TCR-, the re-The use of clones and hybridomas, which may not be
representative of the entire polyclonal population of  sulting TCRs did not contain CD3 (Backstrom et al.,
1998). Third, comparison of the resolved crystal struc-T cells, may explain the discrepancy in the reported
structures. Indeed, our results indicate that some TCRs tures of the human TCR- and TCR- heterodimers
has revealed dissimilarities, particularly within the CCexpressed on primary murine and human  T cells con-
tain CD3. Whether this represents a small subset of and CC domains (Allison et al., 2001). Because the
CD3 subunits associate with the constant regions ofTCRs on each  T cell or the existence of distinct sub-
populations of cells that express TCRs that contain the clonotypic TCR chains, these dissimilarities suggest
that the interaction between the clonotypic chains andCD3 remains to be determined.
The absence of CD3 from TCRs on ex vivo  T cells the CD3 subunits may differ between the - and TCR
complexes (Allison et al., 2001). Finally, previous datais not due to defects in CD3 transcription or translation,
as the levels of CD3 message and CD3 monomers have demonstrated a direct association between CD3
and TCR-, which is thought to be the structural homo-were similar inandT cells. Using a T cell hybridoma
that expresses both - and TCRs (Saito et al., 1988), log of TCR- (Van Neerven et al., 1990).
In view of the different structure of the TCR andwe showed that, within the same cell, CD3 dimers
could be detected in the TCR complex while they the TCR, it was of particular interest to determine if
these complexes exhibited distinct signaling responses.could not be detected in the TCR complex. This find-
ing suggests that CD3 dimers fail to assemble with TCRs lacking CD3 display profound defects in sig-
naling (Delgado et al., 2000; Werlen et al., 2000). Inthe TCR- and TCR- chains and, consequently, are
excluded from the fully assembled TCR complex. CD3/ mice, crosslinking of the TCR on DP thymo-
cytes fails to induce the phosphorylation of TCR- andProper assembly of the TCR requires pairing of the
TCR- heterodimer with both CD3 and CD3 di- LAT or the activation of ERK (Delgado et al., 2000). Inter-
estingly, similar signaling defects are observed in trans-mers. The TCR may differ in its requirements for as-
sembly, in that the TCR- heterodimer may pair with genic mice that express an TCR in which the trans-
membrane and cytoplasmic regions of TCR- and TCR-two CD3 dimers. Several lines of evidence support
TCR Structure and Signaling Potential
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have been replaced by corresponding regions from quirements for CD28 costimulation between  and 
TCR- and TCR- and where the short, highly conserved T cells could be due to differences in the signaling path-
extracellular connecting peptide motif of TCR- chain ways triggered by the - and TCR complexes, the
(-CPM) has been substituted with corresponding se- distinct structures of the - and TCR complexes, or
quences from TCR- (Werlen et al., 2000). Significantly, both.
in mutant -CPM Tg mice, CD3 is not associated with  and  T cells contribute differently to the immune
the transgenic TCR complex (Backstrom et al., 1998). response. The majority of  T cells are localized in
However, our results demonstrate that signaling through epithelial tissues (reviewed by Hayday, 2000), where
the TCR is not impaired in the absence of CD3, as most pathogens invade the body, whereas most  T
it can induce phosphorylation of TCR- and LAT, mobili- cells circulate through the secondary lymphoid organs.
zation of Ca2, and activation of MAPKinases. An expla- In addition, unlikeT cells,T cells are not dependent
nation for this apparent discrepancy in signaling proper- on antigen processing and presentation for antigen rec-
ties may be that the TCR is more stable than the ognition but are capable of recognizing native antigens
TCR in the absence of CD3. In both mutant -CPM (reviewed by Hayday, 2000). The enhanced signaling
Tg and CD3/ mice, TCR- is weakly associated with proficiency of the TCR may enable  T cells to re-
the TCR complexes expressed on the surface of DP spond rapidly during an immune response in the ab-
thymocytes (Dave et al., 1997; Werlen et al., 2000). How- sence of CD28 costimulation by professional antigen-
ever, TCR- is stably associated with the TCR, as it presenting cells. Indeed, other investigators have shown
can be coimmunoprecipitated with antibodies against that  T cells acquire effector functions faster than
either the TCR or CD3 from  T cells lysed in 1%  T cells (Hiromatsu et al., 1992; Ferrick et al., 1995).
Brij 97 or in 1% Triton X-100 (data not shown). Therefore, Therefore, the differences in the contributions of  and
the instability of the TCR in the absence of CD3,  T cells to the immune response may be explained,
rather than the absence of CD3-mediated signals, may in part, by the distinct structure and signaling potential
be responsible for the TCR signaling defects ob- of the - and TCR complexes.
served in CD3/ and mutant -CPM Tg mice. It is
also possible that the difference in signaling proficiency Experimental Procedures
exhibited by mutant -CPM Tg and CD3-deficient
MiceTCRs and the TCR could be due to differences in
B6.129-TCR-/ (TCR-/) mice (Mombaerts et al., 1993) wereexpression of other signaling components in  and 
purchased from The Jackson Laboratory (Bar Harbor, ME). B6.129-T cells. However, our analysis of downstream effectors
pT/ (pT/) (Fehling et al., 1995) and C57BL/6-V6/V1 TCRof TCR signaling has so far failed to reveal any such
Tg (TCR Tg, line 134) (Sim et al., 1995) mice were provided by
differences. For example, ZAP-70 but not Syk was found B.J. Fowlkes (NIH, Bethesda, MD). B6.129-FcR1/ (FcR/) mice
in whole-cell lysates from both ex vivo  and  T cells (Takai et al., 1994) were provided by Jeffrey Ravetch (Rockefeller
(data not shown). In any event, our data demonstrate University, New York, NY). B6.129-TCR-/ (TCR-/) (Love et al.,
1993), C57BL/6-huFcR1 Tg (huFcR Tg) (Flamand et al., 1996),that CD3 is not required to couple the TCR to down-
and C57BL/6 (B6) mice were generated in our animal facility. Allstream signaling pathways leading to ERK activation,
mice were sacrificed at 5 to 7 weeks of age for experiments.calcium mobilization, and proliferation.
Our comparative analysis of the signaling potential of
Antibodies, Reagents, and Cells- and TCRs suggested that the TCR may be a
Antibodies used for flow cytometric analysis included PerCP-better signal-transducing complex than the TCR.
labeled anti-CD4 (RM4-5), APC-labeled anti-CD8 (53-6.7), PE-
Consequently, it was of interest to determine whether labeled anti-TCR (GL3), PE-labeled anti-TCR (H57-597), and
this difference in signaling proficiency influenced the FITC-labeled anti-CD3 (145-2C11), all of which were purchased
functional responses of  and  T cells. Because  from PharMingen (San Diego, CA). Antibodies used for cell separa-
tion were FITC-labeled anti-B220 (RA3-6B2), FITC-labeled anti-and  T cells secrete, for the most part, different ef-
TCR- (H57-597), FITC-labeled anti-CD4 (RM4-5), FITC-labeled anti-fector cytokines and chemokines (reviewed by Hayday,
CD8 (53-6.7), and FITC-labeled DX5 (PharMingen). Biotinylated2000), it was necessary to choose a functional readout
anti-CD3 (145-2C11), also purchased from PharMingen, was usedof activation that both T cells would have in common in conjunction with streptavidin (GIBCO BRL, Gaithersburg, MD) to
to enable a direct comparison of these cells. For this crosslink the TCR. Antibodies used for stimulation and biochemical
purpose, we measured the proliferative response of  analyses included purified anti-murine TCR (UC7-13D5), anti-
and  T cells following CD3 stimulation. Significantly, murine TCR- (H57-597), anti-CD3 (145-2C11), anti-CD28 (37.51)
(PharMingen), anti-human TCR (5A6.E9), anti-human TCRat every concentration of anti-CD3 mAb, we found that
(BMA031) (Endogen, Woburn, MA), hamster anti-TCR- (H146) (pro-the proliferative response of  T cells was superior to
vided by David Wiest, Fox Chase Cancer Center, Philadelphia, PA),that of  T cells. Moreover, the proliferative response
rabbit anti-CD3 (R9), rabbit anti-TCR- (551), rabbit anti-LAT (pro-
of  T cells to anti-CD3 alone was equivalent to the vided by Lawrence Samelson, NIH, Bethesda, MD), goat anti-CD3
proliferative response of  T cells activated by anti- (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-FcR1 ,
CD3 plus anti-CD28. The enhanced proliferation of  anti-phosphotyrosine (4G10) (Upstate Biotechnology, Lake Placid,
T cells relative to  T cells following TCR engagement NY), anti-phospho-ERK1/2, anti-ERK1/2, anti-phospho-JNK, anti-
JNK, anti-phospho-p38, anti-p38 (Cell Signaling Technology, Bev-may be due to an increase in the number of proliferating
erly, MA), protein A-HRP (Transduction Laboratories, Lexington,cells or to an increase in cell survival in the absence of
KY), donkey anti-goat IgG (H  L)-HRP, and donkey anti-mouse IgGCD28 costimulation. In addition, activation of both 
(H  L)-HRP (Jackson ImmunoResearch, West Grove, PA).
and  T cells by PMA and ionomycin, which bypasses Human peripheral blood lymphocytes from healthy donors were
TCR signaling, resulted in a comparable proliferative isolated by elutriation at the NIH Blood Bank. The mouse fibroblast
response between the two T cell populations. The differ- line L929 was kindly provided by Michael Princiotta (NIH, Bethesda,
MD), and the TCR and TCR T cell hybridoma (DN1-.-1.3;ences in both the kinetics of proliferation and the re-
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Saito et al., 1988) was kindly provided by Ronald Germain (NIH, Measurement of Ca2 Mobilization
Ca2 mobilization was measured as previously described (SommersBethesda, MD).
et al., 1999). The ratio of indo-1 bound and unbound to calcium was
calculated using the FCSAssistant software.
Flow Cytometry
Flow cytometric analysis was performed as previously described Proliferation Assay
(Shores et al., 1998), except that cells were analyzed on a Becton Purified  and  T cells were labeled with CFSE as previously
Dickinson FACScalibur using CELLQuest software (Becton Dickin- described (Sommers et al., 1999). Cells (0.5 
 106 ) were stimulated
son Immunocytometry Systems, San Jose, CA). on 12-well plates with immobilized anti-CD3 (145-2C11, 1–20 	g),
anti-CD28 (37.51, 10 	g), anti-CD3 and anti-CD28 (10 	g each), or
with PMA (10 ng/ml) and ionomycin (1 	M). After 48 hr, proliferation
Cell Separation
was assessed by flow cytometric analysis.
To purify  T cells, lymph node cells from B6 mice were stained
for 10 min with anti-B220-FITC, washed, and then incubated with
Stimulation and Expansion of  T Cells In Vitroanti-FITC MACS beads (Miltenyi, Auburn, CA) for 15 min. All steps
TCR Tg lymph node cells were stimulated as described (Qian etwere performed on ice. Cells were then separated on an AUTOMACS
al., 1993). Briefly, 3 
 106 unfractionated TCR Tg lymph nodecell separator, according to manufacturer’s directions (Miltenyi).
cells were stimulated on 6-well plates coated with anti-TCR mAbThis purification scheme results in a cell population in which 98%
(GL4; 15 	g/ml) for 2 days and expanded in the presence of 40 U/mlof the cells express the TCR. To purify  T cells, lymph node
human recombinant IL-2 (Peprotech, Inc., Rocky Hill, N.J.) for 4cells from TCR Tg, pT/, or TCR-/ mice were stained for 10
more days. At the end of the culture period, 99% of the cells weremin on ice with a panel of FITC-labeled mAbs containing anti-B220,
TCR, with no contamination by TCR cells.anti-TCR-, anti-CD4, ant-CD8, and DX5 mAbs. Cells were washed
and then incubated with anti-FITC MACS beads for 15 min on ice.
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